Everything is on track. Us Pivotal Trial to kick off this week & the first FDA approval (initial product which will be for children) will be this year.
FDA submission per product is 120-180 days. The submissions can be while the US Trials are taking place as we will have a rolling data set of US & Aus patients coming in.
You will then find a rolling FDA approval timeline as each product for each age group (children & adults) will be submitted & approved.
The US hospital kick-off will get the media ball rolling in the US also which will attract major US instos.
$1-$2 by the end of this year is very much on the cards.
RAP Price at posting:
40.0¢ Sentiment: Buy Disclosure: Held